While World Cup fever has been captivating much of the United States, a local family is preparing for another world-class ...
South Jersey's most prominent figures include a soap opera star, the U.S. Navy's first woman doctor and a dinosaur discoverer ...
Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) has secured a proposed international nonproprietary name (pINN) from the World Health Organization for its investigational cancer therapy HMBD-002, ...
TikTok viewers are amazed by Howard, a colossal Percheron horse whose size becomes even more impressive when he’s seen beside a man who himself is six feet tall. Despite his enormous stature, Howard’s ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Elon Musk's X played a starring role in another weekend internet kerfuffle. It began when Nikita Bier, ...
COLORADO SPRINGS, Colo. (KRDO) - KRDO13's Bradley Davis walks us through the Percheron Community, one of the fastest-growing housing developments in Northeast Colorado Springs. The Colorado Springs ...
Hummingbird Bioscience could one day feather its nest with up to $290 million if its decision to license a phase 2-ready cancer drug to Percheron Therapeutics pays off. In return for up to $290 ...
Walking through his horse barn late last week, Dennis Clark was still mulling his lineup. Kate and Lucy, weighing in at about a ton each, would be excellent candidates for the lead team. “Leaders have ...
SAN FRANCISCO — Percheron Capital (“Percheron”), a private equity firm, announced the formation of its fire and life safety platform alongside industry executive Carmine Schiavone. Percheron said its ...
Carmine Schiavone, a seasoned executive in the fire and life-safety industry, has partnered with Percheron Capital to launch a new fire and life safety platform backed by the private equity firm. The ...
Forbes contributors publish independent expert analyses and insights. Kate O’Flaherty is a cybersecurity and privacy journalist. Elon Musk’s AI firm xAI has purchased X, formerly Twitter in a $33 ...
Percheron has detailed why its Duchenne muscular dystrophy trial flopped – and why it needs to find a new drug candidate Imugene’s multiple oncology and inflammation programs aren’t helping its ...